Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI

OBJECTIVE: To assess the diagnostic value of gadolinium (Gd) contrast administration in MRI follow-up examinations of patients with MS if the T2 lesion load is stable. METHODS: We included 100 patients with MS with at least 2 cranial MRI follow-up examinations (mean follow-up time 4.0 ± 2.6 years)....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurol Neuroimmunol Neuroinflamm
Hlavní autoři: Karimian-Jazi, Kianush, Wildemann, Brigitte, Diem, Ricarda, Schwarz, Daniel, Hielscher, Thomas, Wick, Wolfgang, Bendszus, Martin, Breckwoldt, Michael O.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6053940/
https://ncbi.nlm.nih.gov/pubmed/30038948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000480
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky